Skip to main content
. 2014 Jul 15;2014:570698. doi: 10.1155/2014/570698

Table 2.

Clinical characteristics and carotid-femoral pulse wave velocity levels of 93 geriatric adults.

Characteristic Number (%) cfPWV (m/s) P value
Gender Male 63 (67.7) 10.07 ± 2.60 0.869
Female 30 (32.3) 10.17 ± 3.25

Diabetes No 49 (52.7) 9.37 ± 2.52 0.007
Yes 44 (47.3) 10.92 ± 2.92

Dyslipidemia No 49 (52.7) 9.50 ± 2.38 0.029
Yes 44 (47.3) 10.77 ± 3.11

Hypertension No 56 (60.2) 9.93 ± 2.80 0.473
Yes 37 (39.8) 10.36 ± 2.85

ACE inhibitor No 77 (82.8) 10.11 ± 2.83 0.973
Yes 16 (17.2) 10.08 ± 2.79

ARB No 67 (72.0) 9.95 ± 2.80 0.409
Yes 26 (28.0) 10.49 ± 2.85

β-Blocker No 71 (76.3) 10.07 ± 2.09 0.841
Yes 22 (23.7) 10.21 ± 2.61

CCB No 71 (76.3) 9.98 ± 2.74 0.457
Yes 22 (23.7) 10.49 ± 3.05

Statins No 70 (75.3) 10.19 ± 2.91 0.583
Yes 23 (24.7) 9.82 ± 2.52

Fibrate No 75 (80.6) 10.11 ± 2.84 0.937
Yes 18 (19.4) 10.06 ± 2.74

Data are expressed as means ± standard deviations.

P < 0.05 was considered statistically significant after Student's t-test.

cfPWV, carotid-femoral pulse wave velocity; CAD, coronary artery disease; CHF, congestive heart failure; ACE, angiotensin-converting enzyme; ARB, angiotensin-receptor blocker; CCB, calcium-channel blocker.